2/5/2014 3 Newsworthy Biotech Stocks: BioDelivery, CytRx, TG Therapeutics http://wallstcheatsheet.com/stocks/3-newsworthy-biotech-stocks-biodelivery-cytrx-tg-therapeutics.html/?ref=YF 1/5 SUBSCRIBER LOGIN Trending: Apple Tightens Its Grip on PC, Tablet Industry (3:11 PM) Follow 22.3K f STOCK NEWS INVESTING IDEAS ECON & POLICY PERSONAL FINANCE TOOLS FOR INVESTORS Search Quotes o 35k Like HOME / BREAKING NEWS / 3 Newsworthy Biotech Stocks: BioDelivery, CytRx, TG Therapeutics Over the past few weeks, there have been a significant number of important announcements in the biotechnology industry. Three companies that have released extremely important news that investors should be aware of are BioDelivery Sciences (NASDAQ:BDSI ), CytRx Corp. (NASDAQ:CYTR ), and TG Therapeutics (NASDAQ:TGTX ). JAMES RATZ | MORE ARTICLES FEBRUARY 03, 2014 Page 1 of 3 view all Advertisement Advertisement Trade with TradeStation Trad commissionfree for 90 days. More. Advertisement
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Over the past few weeks, there have been a significant number ofimportant announcements in the biotechnology industry. Threecompanies that have released extremely important news thatinvestors should be aware of are BioDelivery Sciences(NASDAQ:BDSI), CytRx Corp. (NASDAQ:CYTR), and TGTherapeutics (NASDAQ:TGTX).
JAMES RATZ | MORE ARTICLESFEBRUARY 03, 2014
Page 1 of 3view all
Advertisement
Advertisement
Trade with TradeStation Tradecommissionfree for 90 days. More.
BioDelivery Sciences is a specialty pharmaceutical company thatis leveraging its patented drug delivery techniques to develop andcommercialize new applications of proven therapeutics. Thecompany is focused on the areas of pain management andaddiction. After the market close on January 23, BioDeliverySciences announced positive top-line results from its pivotalPhase 3 trial of BEMA Buprenorphine in opioid-naive patients. Thecompany is developing BEMA Buprenorphine for the treatment ofmoderate to severe chronic pain in patients that require opioidtherapy.
Shares of the company jumped by more than 50 percent after theannouncement but have since cooled off. That being said, theshare price of BioDelivery Sciences is still higher than the pre-announcement share price by nearly 26 percent. The positiveresults from the Phase 3 trial mean that the company will receive a$10 million milestone payment from its partner, Endo HealthSolutions (NASDAQ:ENDP). The company is also evaluating BEMABuprenorphine in opioid “experienced” patients and expects toannounce results from the Phase 3 trial later this year. Ifsuccessful, investors can anticipate another large milestonepayment to BioDelivery Sciences.
Page 1 of 3view all
1. SmallCap Biotech
Stocks2. Stock Picks for 2014
3. Top 10 Biotech
4. Hot Penny Stocks
5. Top Pharma Stocks
6. Biotech Stocks to Buy
YOU MAY ALSO LIKE
The New Diet Pill That Has Doctors RavingAll Consumer Health Tips
Shocking New Weight Loss Discovery Is Not Just Another Skinny PillBetter Body Advice
BROKER PARTNERS
4 Biggest Box OfficeSurprises in January
10 Cars and TrucksThat Survived thePolar Vortex
Celebrity DeathsHighlight StarkReality: Heroin Use
Homeowners Are In For A Big Surprise…Smart Life Weekly
You Won't Believe Who's Related to Abraham LincolnAncestry.com
20 Celebrities Who Shockingly Used To Be HotAnswers
bRight Switch: The next generation of wall technology.Indiegogo
Actress Has Wardrobe Malfunction So Bad You Won't Believe It (PHOTO)Tasty Articles
Enter email address... Click Here, It's Free!
The Death of the PCThe days of paying for costly software upgrades are numbered. The PC will soon beobsolete. And BusinessWeek reports 70% of Americans are already using thetechnology that will replace it. Merrill Lynch calls it "a $160 billion opportunity."Computing giants including IBM, Yahoo!, and Amazon are racing to be the first to cashin on this PCkilling revolution. Yet, a small group of littleknown companies have a hugehead start. Get the full details on these companies, and the technology that is destroyingthe PC, in a free video from The Motley Fool. Enter your email address below to viewthis stunning video.
The Motley Fool Terms And Conditions
Wall St. Cheat Sheet Privacy Policy
More Articles About: BioDelivery Sciences biopharmaceutical companies
Biotech Industry biotechnology CytRx CytRx Corp. drugs
drugs development Investing NASDAQ:BDSI pharmaceuticals